-
Symbol
-
TRVI on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Ownership
-
1.27M shares
-
Security Ownership
-
1.4%
Venrock Healthcare Capital Partners II, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)
2025-02-14 - Venrock Healthcare Capital Partners II, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.27M shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI).
This represents 1.4% percent ownership of the company.